LEX Diagnostics
Founded 2020
About LEX Diagnostics
LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care. Having solved the PCR cost problem, LEX focuses tightly on nasal and oral samples, and on viral pathogens, to avoid the other high-cost elements of traditional molecular diagnostic products. LEX Diagnostics is a spin-out from TTP plc, a technology development company in the life science and medical device sector. The origins of the LEX technology lie in an internal R&D project to reduce the time it takes to get a result from a PCR test. It formed a company when it became clear the solution also reduced the cost and size of any diagnostic device using it. LEX Diagnostics was founded in 2020 and is based in Melbourn, United Kingdom.
Company Facts
- Founded: 2020
- Legal name: LEX Diagnostics Limited
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Website: lexdiagnostics.com
- Phone: +44 1223 752144
Social Profiles
Canonical: https://fsome.com/organization/lex-diagnostics-8251155 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.